GCSG 2025 European Knowledge Forum
Clinical supply, CDMO, and CRO solutions to simplify, accelerate, and scale your clinical trials
October 14–16, 2025 | Corinthia Hotel, Budapest
About GCSG 2025
The Global Clinical Supplies Group (GCSG) provides a collaborative platform for professionals to share knowledge and advance best practices in clinical supplies. Through global events, GCSG fosters a friendly, patient-centered community while offering valuable educational and professional development opportunities.
Now in its 11th year, the European Knowledge Forum is a leading venue for clinical supply professionals to connect, learn, and benchmark solutions to today’s most pressing clinical supply chain challenges. As a long-time supporter, Thermo Fisher Scientific is proud to return to GCSG to highlight its integrated clinical supply, CDMO, and CRO services.
Event details
Date: October 14-16, 2025
Format: In-person
Location: Corinthia Hotel, Budapest
Booth: Thermo Fisher Scientific booth
Event website: GCSG 2025 European Knowledge Forum – GCSG
Why Thermo Fisher Scientific?
Thermo Fisher Scientific supports biotech and pharma companies with comprehensive clinical trial supply capabilities—drawing on more than 35 years of experience in the space. Our services cover investigational medicinal products (IMPs), comparators, co-medications, and ancillary supplies. From strategic planning, sourcing, and inventory management to packaging, labeling, storage, and global distribution—we’re built to support clinical trial success.
Through our Accelerator™ Drug Development, 360° CDMO and CRO solutions, we help simplify execution, reduce handoffs, and accelerate timelines—empowering customers to bring treatments to patients faster.
Attend our vendor showcase
“Reframing ROI: Unlocking the value of integrated CDMO, CRO, and clinical supply services in clinical trial execution”
- Date: Tuesday, October 14, 2025
- Time: 4:30–5:30 p.m. CEST
What’s the measurable value of working with a single partner across clinical development and manufacturing?
In this session, the Tufts Center for the Study of Drug Development will present findings from a new independent study that uses expected Net Present Value (eNPV) modeling to quantify the financial and operational impact of integrating CDMO, CRO, and clinical supply services. Thermo Fisher’s Accelerator™ Drug Development framework serves as the reference model, with analysis accounting for real-world complexity and risk-adjusted progression.
Following the data walkthrough, Luke Wilson, senior director of biotech commercial operations at Thermo Fisher Scientific, will share industry insights and real-world examples showing how integrated support, especially at the intersection of clinical operations and supply, can streamline execution and improve ROI across development programs.
Speakers:
- Ken Getz, Executive Director and Professor | Tufts Center for the Study of Drug Development
- Luke Wilson, Senior Director, Commercial Operations | Thermo Fisher Scientific
Let’s connect at GCSG 2025
Connect with a Thermo Fisher Scientific representative at GCSG EU to learn more about our integrated clinical supply, CDMO, and CRO solutions. Whether you're looking to simplify your trial logistics, scale globally, or streamline operations, our team is here to help.
We look forward to connecting in Budapest.
Continuing education for the pharma industry
Follow us on social for event updates
We look forward to seeing you soon